levodopa has been researched along with tamoxifen in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (50.00) | 18.7374 |
1990's | 1 (5.00) | 18.2507 |
2000's | 3 (15.00) | 29.6817 |
2010's | 6 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Marchant, J | 2 |
Davis, HL; Legha, SS; Muggia, FM | 1 |
Ward, HW | 1 |
Costa, M; Di Benedetto, G; Gallamini, A; Indiveri, F; Nizzo, MC | 1 |
Bartsch, O; Busse, E; Kornhuber, B | 1 |
Ivanova, OA; Moiseenko, VM; Semiglazov, VF | 1 |
Cueto Ladrón de Guevara, J; García Puche, JL; Pedraza, V | 1 |
Hakim, AA | 1 |
Moiseenko, VM; Semiglazov, VF | 1 |
Gnatyshak, AI | 1 |
Chambon, P; Ichinose, H; Ikeguchi, K; Kodera, M; Li, XG; Metzger, D; Muramatsu, C; Muramatsu, S; Nakano, I; Nara, Y; Okada, T; Ozawa, K; Takino, N; Urano, F | 1 |
Avila, I; Bibbiani, F; Chase, TN; Collins, MA; Oh, JD; Smith, CP | 1 |
An, L; Li, X; Li, Z; Mao, Y; Wu, X; Zhu, G | 1 |
3 review(s) available for levodopa and tamoxifen
Article | Year |
---|---|
Hormonal therapy of breast cancer: new approaches and concepts.
Topics: Adrenalectomy; Breast Neoplasms; Castration; Clomiphene; Ergotamines; Estrogen Antagonists; Female; Humans; Hypophysectomy; Levodopa; Nafoxidine; Neoplasm Metastasis; Prolactin; Receptors, Estrogen; Tamoxifen | 1978 |
[Hormone therapy of patients with breast cancer].
Topics: Adrenalectomy; Aminoglutethimide; Breast Neoplasms; Castration; Combined Modality Therapy; Drug Resistance; Estrogens; Female; Hormones; Humans; Hypophysectomy; Levodopa; Mastectomy; Menopause; Progestins; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
[Antiestrogens in the treatment of breast cancer].
Topics: Adult; Blood Proteins; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Estrogen Antagonists; Female; Homeostasis; Humans; Levodopa; Ligands; Male; Menopause; Middle Aged; Tamoxifen | 1981 |
2 trial(s) available for levodopa and tamoxifen
Article | Year |
---|---|
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting | 1977 |
[Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Female; Fluorouracil; Humans; Levodopa; Menopause; Methotrexate; Middle Aged; Neoplasms, Hormone-Dependent; Prospective Studies; Random Allocation; Tamoxifen | 1986 |
15 other study(ies) available for levodopa and tamoxifen
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Prophylactic chemotherapy following breast cancer: a personal experience.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Female; Humans; Levodopa; Neoplasm Metastasis; Razoxane; Tamoxifen | 1977 |
[Effects of the treatment with an antiestrogen(tamoxifen) and levodopa on the secretion of prolactin in patients affected by breast cancer].
Topics: Adult; Breast; Breast Neoplasms; Female; Humans; Levodopa; Mastectomy; Menopause; Prolactin; Stilbenes; Tamoxifen | 1976 |
Letter: Prophylactic chemotherapy for breast cancer.
Topics: Breast Neoplasms; Female; Humans; Levodopa; Neoplasm Metastasis; Tamoxifen | 1976 |
Non-myelotoxic antitumour effects of L-dopa, buthionine sulphoximine and tamoxifen on neuroblastoma cells in vitro and in vivo.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antineoplastic Agents; Buthionine Sulfoximine; Cell Survival; Cyclic AMP; Glutathione; Humans; Levodopa; Male; Methionine Sulfoximine; Mice; Mice, Nude; Monophenol Monooxygenase; Neuroblastoma; Tamoxifen; Tumor Cells, Cultured | 1991 |
[Prolactin and cancer of the breast. II. Prediction of the response to hormone treatment. The Minton test].
Topics: Breast Neoplasms; Combined Modality Therapy; Female; Humans; Levodopa; Medroxyprogesterone; Ovariectomy; Prognosis; Prolactin; Tamoxifen | 1985 |
Correlation between tyrosine hydroxylase activity, melanogenesis, and estradiol binding in human melanoma cells.
Topics: Breast Neoplasms; Cell Line; Cytosol; Estradiol; Fibroblasts; Humans; Kinetics; Levodopa; Melanins; Melanoma; Tamoxifen; Tyrosine; Tyrosine 3-Monooxygenase | 1982 |
Viral-mediated temporally controlled dopamine production in a rat model of Parkinson disease.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Cell Line; Corpus Striatum; Dependovirus; Disease Models, Animal; Dopamine; Estrogen Receptor alpha; Estrogen Receptor Modulators; Genetic Therapy; Genetic Vectors; Humans; Integrases; Levodopa; Male; Mice; Neurons; Parkinson Disease; Rats; Rats, Wistar; Recombination, Genetic; Stereotyped Behavior; Tamoxifen; Tyrosine 3-Monooxygenase; Viral Proteins | 2006 |
Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Disease Models, Animal; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Haplorhini; Levodopa; Male; Models, Biological; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Protein Kinase C; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors | 2007 |
Tamoxifen activates hypothalamic l-dopa synthesis to stimulate ovarian estrogen production in chicken.
Topics: Animals; Chickens; Dose-Response Relationship, Drug; Estrogens; Female; Hypothalamus; Levodopa; Ovary; Ovulation; Ovulation Induction; Selective Estrogen Receptor Modulators; Tamoxifen | 2018 |